|
NOL8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58650000026128E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46779999998792E-06 |
| Normal-vs-Stage2 |
4.580500E-03 |
| Normal-vs-Stage3 |
2.206600E-04 |
| Normal-vs-Stage4 |
1.031770E-04 |
| Stage1-vs-Stage2 |
9.419000E-01 |
| Stage1-vs-Stage3 |
8.778600E-01 |
| Stage1-vs-Stage4 |
3.333200E-01 |
| Stage2-vs-Stage3 |
8.707200E-01 |
| Stage2-vs-Stage4 |
5.263800E-01 |
| Stage3-vs-Stage4 |
3.213800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80559999951591E-07 |
| Normal-vs-AfricanAmerican |
3.330100E-02 |
| Normal-vs-Asian |
2.043800E-02 |
| Caucasian-vs-AfricanAmerican |
5.826500E-02 |
| Caucasian-vs-Asian |
3.640600E-03 |
| AfricanAmerican-vs-Asian |
4.533500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41739999998314E-06 |
| Normal-vs-Female |
1.31119999968732E-07 |
| Male-vs-Female |
2.177200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.372500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.48460000141071E-08 |
| Normal-vs-Age(61-80Yrs) |
1.53096999999658E-05 |
| Normal-vs-Age(81-100Yrs) |
4.799000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.434400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.884200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.989200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.441800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.979800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.085840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.387100E-04 |
| Normal-vs-Grade 2 |
1.22420000026047E-07 |
| Normal-vs-Grade 3 |
7.87570000000404E-05 |
| Normal-vs-Grade 4 |
1.742820E-03 |
| Grade 1-vs-Grade 2 |
4.641600E-01 |
| Grade 1-vs-Grade 3 |
1.369180E-01 |
| Grade 1-vs-Grade 4 |
4.281000E-01 |
| Grade 2-vs-Grade 3 |
8.891700E-02 |
| Grade 2-vs-Grade 4 |
9.543600E-01 |
| Grade 3-vs-Grade 4 |
3.814400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.27029997631922E-09 |
| Normal-vs-ccB subtype |
7.815800E-04 |
| ccA subtype-vs-ccB subtype |
5.975400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15320000004804E-06 |
| Normal-vs-N1 |
7.399900E-02 |
| N0-vs-N1 |
6.894800E-01 |
|
|
